When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BMY - Why I'm Big On The Celgene/Bristol-Myers Deal
Bristol-Myers Squibb Company
August 27, I updated subscribers on the Bristol-Myers (BMY) and Celgene (CELG) deal. It looked very attractive. Today, it looks even more attractive to me. Here are my three reasons to buy/add; 1) Bristol-Myers made a deal with Amgen (AMGN), contingent upon FTC consent decree and closing of the Celgene deal, to acquire OTEZLA for $13.4 billion in cash. 2) There is a contingent value right involved 3) I expect it to close before year-end, odds of a break are low by now and if the CVR is worth anything, the